Aldevron News
Meeting mRNA Demand
June 7, 2023 / by Ellen shafer
Demand for mRNA continues to rise and earlier this Spring, we announced the expansion of our mRNA custom manufacturing— going from a cell bank to a drug product — to help meet demand. Doing that required combining our capabilities with the technologies and expertise of two other Danaher companies, Cytiva and Precision NanoSystems Inc. (PNI). Genetic Engineering News covered the story, interviewing Todd Howren/ PhD, Aldevron's VP of RNA.